Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 31, 2023 - Issue 3
Submit an article Journal homepage
195
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Keratoconjunctivitis as a Single Entity in X-linked Agammaglobulinemia?

Stefan Mielkea Department of Ophthalmology, University Medical Center, Greifswald, GermanyCorrespondence[email protected]
View further author information
, Dr. med,
Bastian Grundela Department of Ophthalmology, University Medical Center, Greifswald, GermanyView further author information
, Dr. med,
Sebastian M. Schmidtb Department of Pediatrics, University Medical Center, Greifswald, GermanyView further author information
, PD Dr. med &
Frank Tosta Department of Ophthalmology, University Medical Center, Greifswald, GermanyView further author information
, Prof. Dr. med
Pages 665-670 | Received 30 Mar 2021, Accepted 01 Feb 2022, Published online: 11 Apr 2022

References

  • Lackey AE, Ahmad F. X-linked Agammaglobulinemia. [Updated 2021 Jul 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549865/
  • de WM, Brouns GS, Hinshelwood S, et al. B-cell antigen receptor stimulation activates the human Bruton’s tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J Biol Chem. 1994;269:23857–23860. doi:10.1016/S0021-9258(19)51014-6.
  • Smith CE, Berglöf A. GeneReviews®: X-Linked Agammaglobulinemia. Seattle (WA); 1993.
  • Winkelstein JA, Marino MC, Lederman HM, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore). 2006;85:193–202. doi:10.1097/01.md.0000229482.27398.ad.
  • Gokce G, Ceylan OM, Uysal Y, Yildizoglu U, Atas E, Kurt B. Epiphora as the presenting sign of relapsed non-Hodgkin lymphoma in a child with Bruton agammaglobulinemia. Eur J Ophthalmol. 2015;25:65–67. doi:10.5301/ejo.5000487.
  • Reisli I, Artac H, van der Burg M, Ozturk BT. Iris atrophy in a patient with X-linked agammaglobulinemia. Can J Ophthalmol. 2007;42:882–883. doi:10.3129/i07-169.
  • Al Ghonaium A, Ziegler JB, Tridgell D. Bilateral chronic conjunctivitis and corneal scarring in a boy with X-linked hypogammaglobulinaemia. J Paediatr Child Health. 1996;32:463–465. doi:10.1111/j.1440-1754.1996.tb00950.x.
  • Hansel TT, O’Neill DP, Yee ML, Gibson JM, Thompson RA. Infective conjunctivitis and corneal scarring in three brothers with sex linked hypogammaglobulinaemia (Bruton’s disease). Br J Ophthalmol. 1990;74:118–120. doi:10.1136/bjo.74.2.118.
  • Abolhassani H, Hirbod-Mobarakeh A, Shahinpour S, et al. Mortality and morbidity in patients with X-linked agammaglobulinaemia. Allergol Immunopathol (Madr). 2015;43:62–66. doi:10.1016/j.aller.2013.09.013.
  • El Asrar Am A, Geboes K, Maudgal PC, Emarah MH, Missotten L, Desmet V. Immunocytological study of phlyctenular eye disease. Int Ophthalmol. 1987;10:33–39. doi:10.1007/BF00202779.
  • Bock F, König Y, Kruse F, Baier M, Cursiefen C. Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefes Arch Clin Exp Ophthalmol. 2008;246:281–284. doi:10.1007/s00417-007-0684-4.
  • Koenig Y, Bock F, Horn F, Kruse F, Straub K, Cursiefen C. Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol. 2009;247:1375–1382. doi:10.1007/s00417-009-1099-1.
  • Doan S, Gabison E, Gatinel D, Duong M-H, Abitbol O, Hoang-Xuan T. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis. Am J Ophthalmol. 2006;141:62–66. doi:10.1016/j.ajo.2005.08.035.
  • Matthew Gray MD, Ansuya Deosaran MD. Phlyctenular Keratoconjunctivitis. https://eyewiki.aao.org/Phlyctenular_Keratoconjunctivitis (accessed 5 January 2022).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.